About Monsanto (NYSE:MON)
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and digital agriculture to assist farmers in decision-making. The Seeds and Genomics segment offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.
Industry, Sector and Symbol
Industry Agricultural Chemicals
Sub-IndustryFertilizers & Agricultural Chemicals
Trailing P/E Ratio21.21
Forward P/E Ratio20.44
Sales & Book Value
Annual Sales$14.64 billion
Price / Sales3.53
Cash Flow$7.26 per share
Price / Cash16.15
Book Value$14.70 per share
Price / Book7.98
Net Income$2.26 billion
Return on Equity42.40%
Return on Assets11.40%
Monsanto (NYSE:MON) Frequently Asked Questions
What is Monsanto's stock symbol?
Monsanto trades on the New York Stock Exchange (NYSE) under the ticker symbol "MON."
How often does Monsanto pay dividends? What is the dividend yield for Monsanto?
Monsanto declared a quarterly dividend on Monday, December 4th. Stockholders of record on Friday, January 5th will be given a dividend of $0.54 per share on Friday, January 26th. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. The ex-dividend date of this dividend is Thursday, January 4th. View Monsanto's Dividend History.
How were Monsanto's earnings last quarter?
Monsanto Company (NYSE:MON) released its quarterly earnings data on Wednesday, October, 4th. The basic materials company reported $0.20 EPS for the quarter, beating the consensus estimate of ($0.41) by $0.61. The basic materials company had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company's quarterly revenue was up 4.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.07 EPS. View Monsanto's Earnings History.
When will Monsanto make its next earnings announcement?
Where is Monsanto's stock going? Where will Monsanto's stock price be in 2017?
11 analysts have issued 1-year target prices for Monsanto's shares. Their forecasts range from $105.00 to $128.00. On average, they expect Monsanto's stock price to reach $123.67 in the next twelve months. View Analyst Ratings for Monsanto.
Are investors shorting Monsanto?
Monsanto saw a increase in short interest in the month of November. As of November 15th, there was short interest totalling 4,323,770 shares, an increase of 71.5% from the October 31st total of 2,520,873 shares. Based on an average trading volume of 2,774,952 shares, the short-interest ratio is currently 1.6 days. Approximately 1.0% of the shares of the stock are short sold.
Who are some of Monsanto's key competitors?
Some companies that are related to Monsanto include Syngenta (SYT), Potash Co. of Saskatchewan (POT), Agrium (AGU), Potash Co. of Saskatchewan (POT), Agrium (AGU), Sociedad Quimica y Minera (SQM), Incitec Pivot (IPL), Scotts Miracle-Gro (SMG), Israel Chemicals (ICL), Nufarm (NUF), Compass Minerals International (CMP), Sirius Minerals (SXX), American Vanguard (AVD), Ciner Resources (CINR), Intrepid Potash (IPI) and Marrone Bio Innovations (MBII).
Who are Monsanto's key executives?
Monsanto's management team includes the folowing people:
- Hugh Grant, Chairman of the Board, Chief Executive Officer (Age 58)
- Brett D. Begemann, President, Chief Operating Officer (Age 56)
- Pierre C. Courduroux, Chief Financial Officer, Senior Vice President (Age 51)
- Steven C. Mizell, Chief Human Resource Officer, Executive Vice President (Age 57)
- Robert T. Fraley Ph.D., Executive Vice President, Chief Technology Officer (Age 64)
- David F. Snively J.D., Executive Vice President, General Counsel, Secretary (Age 63)
- Kerry J. Preete, Executive Vice President and Chief Strategy Officer (Age 57)
- Janet M. Holloway, Senior Vice President, Chief of Staff and Community Relations (Age 63)
- Nicole M. Ringenberg, Vice President, Controller (Age 56)
- Duraiswami Narain, Vice President, Treasurer (Age 54)
Who owns Monsanto stock?
Monsanto's stock is owned by a number of of retail and institutional investors. Top institutional investors include Capital International Investors (2.12%), Independent Franchise Partners LLP (0.95%), Flossbach Von Storch AG (0.89%), Bank of New York Mellon Corp (0.82%), Janus Henderson Group PLC (0.53%) and Legal & General Group Plc (0.53%). Company insiders that own Monsanto stock include Andrew Thomson, Brett D Begemann, Charles S Mcmillan, Duraiswami Narain, George Poste, Hugh Grant, Janet M Holloway, Kerry J Preete, Michael J Frank, Michael K Stern, Nicole M Ringenberg, Pierre Courduroux, Robert T Fraley and Steven Mizell. View Institutional Ownership Trends for Monsanto.
Who sold Monsanto stock? Who is selling Monsanto stock?
Monsanto's stock was sold by a variety of institutional investors in the last quarter, including Flossbach Von Storch AG, State of New Jersey Common Pension Fund D, SG Americas Securities LLC, Neuberger Berman Group LLC, Marathon Asset Management LLP, YHB Investment Advisors Inc., Bank of New York Mellon Corp and Numen Capital LLP. Company insiders that have sold Monsanto company stock in the last year include Brett D Begemann, Duraiswami Narain, Hugh Grant, Janet M Holloway, Kerry J Preete, Michael K Stern, Nicole M Ringenberg, Pierre Courduroux, Robert T Fraley and Steven Mizell. View Insider Buying and Selling for Monsanto.
Who bought Monsanto stock? Who is buying Monsanto stock?
Monsanto's stock was bought by a variety of institutional investors in the last quarter, including Harding Loevner LP, Capital International Investors, Janus Henderson Group PLC, Cheyne Capital Management UK LLP, First Eagle Investment Management LLC, Cowen Inc., Vaughan David Investments Inc. IL and Temasek Holdings Private Ltd. Company insiders that have bought Monsanto stock in the last two years include Andrew Thomson and Charles S Mcmillan. View Insider Buying and Selling for Monsanto.
How do I buy Monsanto stock?
Shares of Monsanto can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Monsanto's stock price today?
One share of Monsanto stock can currently be purchased for approximately $117.30.
How big of a company is Monsanto?
Monsanto has a market capitalization of $51.64 billion and generates $14.64 billion in revenue each year. The basic materials company earns $2.26 billion in net income (profit) each year or $5.11 on an earnings per share basis. Monsanto employs 23,300 workers across the globe.
How can I contact Monsanto?
Monsanto's mailing address is 800 NORTH LINDBERGH BLVD., ST LOUIS MO, 63167. The basic materials company can be reached via phone at 314-694-1000 or via email at [email protected]
MarketBeat Community Rating for Monsanto (MON)MarketBeat's community ratings are surveys of what our community members think about Monsanto and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Monsanto (NYSE:MON) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Buy||Buy||Buy|
|Consensus Rating Score: ||2.47||2.50||2.50||2.58|
|Ratings Breakdown: ||0 Sell Rating(s)|
9 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
10 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
8 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$123.50||$120.82||$118.82||$115.06|
|Price Target Upside: ||4.62% upside||0.98% upside||1.38% upside||0.62% downside|
Monsanto (NYSE:MON) Consensus Price Target History
Monsanto (NYSE:MON) Analyst Ratings History
(Data available from 12/11/2015 forward)
Monsanto (NYSE:MON) Earnings History and Estimates Chart
Monsanto (NYSE MON) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/4/2017||Q4 2017||($0.41)||$0.20||$2.51 billion||$2.69 billion||View||N/A|
|6/28/2017||Q3 17||$1.74||$1.93||$4.18 billion||$4.23 billion||View||N/A|
|4/5/2017||Q2 2017||$2.79||$3.19||$4.73 billion||$5.07 billion||View||Listen|
|10/5/2016||Q416||($0.02)||$0.07||$2.38 billion||$2.56 billion||View||Listen|
|6/29/2016||Q316||$2.40||$2.17||$4.49 billion||$4.19 billion||View||Listen|
|4/6/2016||Q216||$2.44||$2.42||$4.81 billion||$4.53 billion||View||N/A|
|1/6/2016||Q116||($0.22)||($0.11)||$2.41 billion||$2.22 billion||View||Listen|
|10/7/2015||Q415||($0.02)||($0.19)||$2.79 billion||$2.36 billion||View||Listen|
|6/24/2015||Q315||$2.06||$2.39||$4.65 billion||$4.58 billion||View||Listen|
|4/1/2015||Q215||$2.93||$2.90||$5.58 billion||$5.20 billion||View||Listen|
|1/7/2015||Q115||$0.35||$0.47||$2.80 billion||$2.87 billion||View||Listen|
|10/8/2014||Q414||($0.24)||($0.27)||$2.41 billion||$2.63 billion||View||Listen|
|6/25/2014||Q314||$1.55||$1.62||$4.41 billion||$4.25 billion||View||Listen|
|4/2/2014||Q214||$3.08||$3.15||$5.81 billion||$5.83 billion||View||Listen|
|1/8/2014||Q1||$0.64||$0.67||$3.08 billion||$3.15 billion||View||Listen|
|10/2/2013||Q413||($0.43)||($0.47)||$2.24 billion||$2.20 billion||View||Listen|
|6/26/2013||Q3 2013||$1.59||$1.66||$4.41 billion||$4.25 billion||View||Listen|
|4/3/2013||Q2 2013||$2.58||$2.73||$5.29 billion||$5.47 billion||View||N/A|
|1/8/2013||Q1 2013||$0.37||$0.62||$2.64 billion||$2.93 billion||View||Listen|
|10/3/2012||Q412||($0.43)||($0.44)||$2.25 billion||$2.11 billion||View||N/A|
Monsanto (NYSE:MON) Earnings Estimates
2017 EPS Consensus Estimate: $5.75
2018 EPS Consensus Estimate: $6.00
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Monsanto (NYSE:MON) Dividend Information
|Dividend Growth:||11.60% (3 Year Average)|
|Payout Ratio:||42.27% (Trailing 12 Months of Earnings) |
37.63% (Based on This Year's Estimates)
34.02% (Based on Next Year's Estimates)
|Track Record:||7 Years of Consecutive Dividend Growth|
Monsanto (NYSE:MON) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Monsanto (NYSE MON) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.79%
Institutional Ownership Percentage: 75.70%
Monsanto (NYSE MON) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/19/2017||Pierre Courduroux||CFO||Sell||4,320||$122.00||$527,040.00|| |
|10/16/2017||Nicole M Ringenberg||VP||Sell||7,890||$122.25||$964,552.50|| |
|10/9/2017||Steven Mizell||EVP||Sell||11,526||$119.70||$1,379,662.20|| |
|9/25/2017||Brett D Begemann||COO||Sell||22,640||$120.03||$2,717,479.20|| |
|9/25/2017||Duraiswami Narain||VP||Sell||2,860||$120.00||$343,200.00|| |
|7/10/2017||Robert T. Fraley||EVP||Sell||52,410||$117.95||$6,181,759.50|| |
|7/3/2017||Steven Mizell||EVP||Sell||11,300||$118.57||$1,339,841.00|| |
|6/13/2017||Janet M Holloway||SVP||Sell||7,423||$118.00||$875,914.00|| |
|6/2/2017||Janet M Holloway||SVP||Sell||3,337||$118.00||$393,766.00|| |
|5/3/2017||Kerry J Preete||EVP||Sell||11,346||$116.86||$1,325,893.56|| |
|4/17/2017||Brett D Begemann||COO||Sell||80,940||$116.13||$9,399,562.20|| |
|4/10/2017||Hugh Grant||CEO||Sell||149,230||$116.15||$17,333,064.50|| |
|4/10/2017||Steven Mizell||EVP||Sell||13,700||$116.11||$1,590,707.00|| |
|1/25/2017||Michael K Stern||CEO||Sell||5,670||$110.00||$623,700.00|| |
|1/10/2017||Steven Mizell||EVP||Sell||2,525||$108.56||$274,114.00|| |
|11/17/2016||Kerry J. Preete||EVP||Sell||2,745||$100.96||$277,135.20|| |
|10/14/2016||Robert T Fraley||EVP||Sell||80,631||$102.04||$8,227,587.24|| |
|10/10/2016||Charles S Mcmillan||Director||Buy||3,500||$103.23||$361,305.00|| |
|10/10/2016||Steven Mizell||EVP||Sell||310||$103.09||$31,957.90|| |
|7/14/2016||Brett D Begemann||COO||Sell||27,980||$103.62||$2,899,287.60|| |
|7/13/2016||Michael K Stern||CEO||Sell||12,797||$101.77||$1,302,350.69|| |
|4/19/2016||George Poste||Director||Sell||1,136||$91.93||$104,432.48|| |
|4/14/2016||Steven Mizell||EVP||Sell||9,500||$89.06||$846,070.00|| |
|4/12/2016||Charles S Mcmillan||Director||Buy||3,500||$87.25||$305,375.00|| |
|4/12/2016||Michael J Frank||VP||Sell||2,000||$87.49||$174,980.00|| |
|4/11/2016||Steven Mizell||EVP||Sell||3,900||$86.87||$338,793.00|| |
|11/17/2015||Kerry J. Preete||EVP||Sell||4,667||$95.62||$446,258.54|| |
|10/21/2015||William U Parfet||Director||Sell||17,000||$91.16||$1,549,720.00|| |
|10/13/2015||Steven Mizell||VP||Sell||6,100||$89.40||$545,340.00|| |
|4/15/2015||Kerry J Preete||EVP||Sell||27,580||$119.37||$3,292,224.60|| |
|4/8/2015||Tom D Hartley||VP||Sell||4,600||$117.91||$542,386.00|| |
|2/13/2015||Michael K Stern||COO||Sell||1,391||$125.00||$173,875.00|| |
|1/20/2015||David F Snively||EVP||Sell||29,521||$117.14||$3,458,089.94|| |
|1/12/2015||Steven Mizell||VP||Sell||20,500||$118.72||$2,433,760.00|| |
|11/17/2014||Nicole M Ringenberg||VP||Sell||12,780||$118.83||$1,518,647.40|| |
|10/15/2014||Robert T Fraley||EVP||Sell||10,679||$107.93||$1,152,584.47|| |
|10/14/2014||Nicole M Ringenberg||VP||Sell||2,500||$108.01||$270,025.00|| |
|10/13/2014||Steven Mizell||VP||Sell||3,480||$106.08||$369,158.40|| |
|9/3/2014||Kerry J Preete||EVP||Sell||3,827||$115.50||$442,018.50|| |
|7/8/2014||Michael J Frank||VP||Sell||7,500||$124.53||$933,975.00|| |
|7/7/2014||Robert T Fraley||EVP||Sell||54,740||$125.32||$6,860,016.80|| |
|7/3/2014||David F Snively||EVP||Sell||35,220||$126.25||$4,446,525.00|| |
|7/3/2014||William U Parfet||Director||Sell||23,800||$126.52||$3,011,176.00|| |
|5/23/2014||Janet M Holloway||SVP||Sell||21,280||$120.00||$2,553,600.00|| |
|5/7/2014||Kerry Preete||EVP||Sell||49,850||$115.00||$5,732,750.00|| |
|4/15/2014||Hugh Grant||CEO||Sell||95,000||$110.33||$10,481,350.00|| |
|4/15/2014||Tom Hartley||VP||Sell||7,900||$110.51||$873,029.00|| |
|1/17/2014||Hugh Grant||CEO||Sell||44,179||$112.69||$4,978,531.51|| |
|1/16/2014||Robert Fraley||EVP||Sell||64,850||$112.57||$7,300,164.50|| |
|1/14/2014||Steven Mizell||VP||Sell||24,000||$112.05||$2,689,200.00|| |
|11/11/2013||Nicole Ringenberg||VP||Sell||13,560||$107.04||$1,451,462.40|| |
|10/15/2013||Tom Hartley||VP||Sell||5,860||$105.70||$619,402.00|| |
|10/8/2013||Steven Mizell||VP||Sell||11,370||$104.50||$1,188,165.00|| |
|10/7/2013||Nicole Ringenberg||VP||Sell||3,500||$105.02||$367,570.00|| |
|9/4/2013||Kerry Preete||EVP||Sell||5,276||$99.00||$522,324.00|| |
|7/19/2013||Gerald A Steiner||EVP||Sell||12,293||$104.00||$1,278,472.00|| |
|7/9/2013||Tom D Hartley||VP||Sell||6,000||$100.15||$600,900.00|| |
|7/8/2013||Janet M Holloway||SVP||Sell||10,700||$98.80||$1,057,160.00|| |
|7/3/2013||Hugh Grant||CEO||Sell||40,000||$97.74||$3,909,600.00|| |
|7/2/2013||Steven Mizell||VP||Sell||37,000||$97.71||$3,615,270.00|| |
|5/13/2013||David F Snively||EVP||Sell||106,366||$107.24||$11,406,689.84|| |
|5/1/2013||Pierre Courduroux||CFO||Sell||5,720||$105.47||$603,288.40|| |
Monsanto (NYSE MON) News Headlines
Monsanto (NYSE:MON) SEC Filings
|Lutz Marcos M (Reporting)|
Statement of changes in beneficial ownership of securities
Monsanto (NYSE:MON) Income Statement, Balance Sheet and Cash Flow Statement
Monsanto (NYSE MON) Stock Chart for Monday, December, 11, 2017